ProShares Ultra Health Care
22 hedge funds and large institutions have $13.4M invested in ProShares Ultra Health Care in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 9 closing their positions.
7.09% less ownership
Funds ownership: 25.35% → 18.25% (-7.1%)
15% less funds holding
Funds holding: 26 → 22 (-4)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
41% less capital invested
Capital invested by funds: $22.7M → $13.4M (-$9.33M)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
+$2.81M |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$1.34M |
| 3 |
PFA
Plotkin Financial Advisors
Chevy Chase,
Maryland
|
+$110K |
| 4 |
BC
Bartlett & Co
Cincinnati,
Ohio
|
+$87.9K |
| 5 |
BCWM
Bartlett & Co Wealth Management
Cincinnati,
Ohio
|
+$87.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$7.74M |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.87M |
| 3 |
IAN
Integrated Advisors Network
Dallas,
Texas
|
-$1.26M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$781K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$280K |
RXL Hedge Fund Activity: Q1 2022 in Review
22 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q1 2022, worth a combined $13.4M — down 41% from $22.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of RXL and 5 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was IMC Chicago, adding an estimated $2.81M. The largest seller was Geneos Wealth Management, exiting entirely with an estimated $7.74M sold.
- 22 institutional investors held ProShares Ultra Health Care (RXL) as of Q1 2022, down from 26 in Q4 2021.
- Funds reported $13.4M of ProShares Ultra Health Care stock for Q1 2022, down 41% quarter-over-quarter.
- 5 funds opened new ProShares Ultra Health Care positions in Q1 2022 and 9 closed out, a net change of -4 holders.
- The largest ProShares Ultra Health Care buyer in Q1 2022 was IMC Chicago, an estimated $2.81M added.
- The largest ProShares Ultra Health Care seller in Q1 2022 was Geneos Wealth Management, an estimated $7.74M sold.
Based on aggregated 13F filings for Q1 2022.